4.3 Emerging microbiota-targeted strategies for the management of hypothyroidism Advances in microbiome research have unveiled novel strategies that complement traditional therapies for hypothyroidism
Instead of aiming immediately toward standard therapeutic dose levels, microdosing focuses on smaller medication exposure, slower escalation, and a gentler patient experience
Researchers continue to study how the combined biological activities represented by BPC-157 and TB-500 influence tissue homeostasis, cellular adaptation, and the complex signaling pathways involved in maintaining physiological integrity following normal biological stress
Chatzopoulou M, Pegklidou K, Papastavrou N, Demopoulos VJ
Patients were included if they met all the following criteria: (1) new-onset type 2 diabetes diagnosed between 1 January 2006 and 31 December 2015, according to International Classification of Diseases, Revision 10 (ICD-10) code (Additional file 1: Table S1) or use of antidiabetic medications by the Anatomical Therapeutic Chemical (ATC) classification codes (Additional file 1: Table S2)
Lambertini M, Patrizi A, Ravaioli GM, Dika E
